Kaleido Biosciences Inc (KLDO) is around the middle of the Biotechnology industry according to InvestorsObserver. KLDO received an overall rating of 39, which means that it scores higher than 39 percent of all stocks. Kaleido Biosciences Inc also achieved a score of 46 in the Biotechnology industry, putting it above 46 percent of Biotechnology stocks. Biotechnology is ranked 88 out of the 148 industries.
What do These Ratings Mean?
Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.
What's Happening With Kaleido Biosciences Inc Stock Today?
Kaleido Biosciences Inc (KLDO) stock is lower by -6.37% while the S&P 500 is up 0.39% as of 3:06 PM on Thursday, Apr 8. KLDO is lower by -$0.51 from the previous closing price of $8.01 on volume of 264,380 shares. Over the past year the S&P 500 has risen 48.95% while KLDO is up 41.78%. KLDO lost -$2.44 per share the over the last 12 months.
Click Here to get the full Stock Score Report on Kaleido Biosciences Inc (KLDO) Stock.
